Cabergolin effect on IVF for endometriosis

Phase 2

Recruiting

• Conditions: Infertility.; Female infertility of other origin; N97.8

• Registration Number: IRCT20091012002576N35
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Approved endometriosis by pathology
Presence good quality embryo

Exclusion Criteria

Hypersensitivity to cbergoline
BMI>30
Diabetes melitus
Hydrosalpinx
Severe male factor
AMH<1

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
?Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Blood sample for BhCG.

Secondary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Heart beat activity in transvaginal sonogram.